[go: up one dir, main page]

NO20081559L - Kit for parenteral administrering av medikamenter - Google Patents

Kit for parenteral administrering av medikamenter

Info

Publication number
NO20081559L
NO20081559L NO20081559A NO20081559A NO20081559L NO 20081559 L NO20081559 L NO 20081559L NO 20081559 A NO20081559 A NO 20081559A NO 20081559 A NO20081559 A NO 20081559A NO 20081559 L NO20081559 L NO 20081559L
Authority
NO
Norway
Prior art keywords
kit
medication administration
drugs
parenteral medication
infusion
Prior art date
Application number
NO20081559A
Other languages
English (en)
Norwegian (no)
Inventor
Flavio Villani
Paolo Magri
Original Assignee
Infa Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infa Sa filed Critical Infa Sa
Publication of NO20081559L publication Critical patent/NO20081559L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NO20081559A 2005-09-29 2008-04-01 Kit for parenteral administrering av medikamenter NO20081559L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001826A ITMI20051826A1 (it) 2005-09-29 2005-09-29 Kit per la somministrazione parenterale di medicamenti
PCT/IB2006/002702 WO2007036792A2 (fr) 2005-09-29 2006-09-29 Trousse pour l'administration parenterale de medicaments

Publications (1)

Publication Number Publication Date
NO20081559L true NO20081559L (no) 2008-06-12

Family

ID=37900123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081559A NO20081559L (no) 2005-09-29 2008-04-01 Kit for parenteral administrering av medikamenter

Country Status (26)

Country Link
US (1) US8182449B2 (fr)
EP (1) EP1928501B1 (fr)
JP (1) JP2009509608A (fr)
KR (1) KR20080058389A (fr)
CN (1) CN101316614A (fr)
AU (1) AU2006296350B2 (fr)
BR (1) BRPI0617588A2 (fr)
CA (1) CA2624047C (fr)
CY (1) CY1116161T1 (fr)
DK (1) DK1928501T3 (fr)
ES (1) ES2534416T3 (fr)
HR (1) HRP20150393T1 (fr)
HU (1) HUE024968T2 (fr)
IL (1) IL190323A (fr)
IT (1) ITMI20051826A1 (fr)
MD (1) MD20080116A (fr)
NO (1) NO20081559L (fr)
PL (1) PL1928501T3 (fr)
PT (1) PT1928501E (fr)
RS (1) RS53934B1 (fr)
RU (1) RU2446828C2 (fr)
SI (1) SI1928501T1 (fr)
TN (1) TNSN08144A1 (fr)
UA (1) UA93060C2 (fr)
WO (1) WO2007036792A2 (fr)
ZA (1) ZA200802745B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110106021A1 (en) * 2009-10-30 2011-05-05 Revance Therapeutics, Inc. Device and Method for Topical Application of Therapeutics or Cosmetic Compositions
US9364433B2 (en) 2011-04-28 2016-06-14 Borje S. Andersson Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
CN103508077A (zh) * 2012-06-25 2014-01-15 贵州益佰制药股份有限公司 一种药物包装系统及静脉给药的试剂盒
WO2020049451A1 (fr) 2018-09-05 2020-03-12 Emcure Pharmaceuticals Ltd. Composition pharmaceutique stable prête à l'emploi à base de carmustine
US20220062213A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Methods and compositions of solabegron for reducing body fat
US20220062288A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Pharmaceutical compositions of vibegron for reducing body fat
WO2023049747A1 (fr) * 2021-09-22 2023-03-30 Elanco Us Inc. Compositions enzymatiques lytiques de streptococcus suis et leurs procédés d'utilisation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3730338A (en) * 1971-03-04 1973-05-01 Kendall & Co Sterile shielded container
US5536413A (en) * 1990-12-03 1996-07-16 Pall Corporation Method for treating a parenteral emulsion-containing medicament fluid
US6232477B1 (en) * 1996-03-25 2001-05-15 Aventis Pharma S.A. Methods of preparing new taxoids and pharmaceutical compositions containing them
JPH105342A (ja) * 1996-06-27 1998-01-13 A S A Sangyo Kk 経腹膜投薬用カテーテル及び投薬容器セット
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
SE9703425D0 (sv) * 1997-09-23 1997-09-23 Pharmacia & Upjohn Ab Prefilled ampooules and manufacture thereof
US6641565B1 (en) * 1998-11-13 2003-11-04 Elan Pharma International Limited drug delivery systems and methods
AUPQ078799A0 (en) * 1999-06-04 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. New use
AU7452900A (en) * 1999-10-18 2001-04-30 Fujisawa Pharmaceutical Co., Ltd. Method for producing liposome preparation
US6489335B2 (en) 2000-02-18 2002-12-03 Gholam A. Peyman Treatment of ocular disease
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
JP2002052067A (ja) * 2000-08-09 2002-02-19 Kyowa Medex Co Ltd 用時薬剤溶解器具、用時溶解型キット製剤用容器及び用時溶解型キット製剤
DK1392254T3 (da) * 2001-04-20 2007-07-02 Univ British Columbia Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
CA2445763A1 (fr) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions et procedes pour le traitement d'etats inflammatoires par des proteines ou polysaccharides contenant des agents anti-microtubules
JP4002747B2 (ja) * 2001-10-26 2007-11-07 株式会社大塚製薬工場 薬剤混合用アダプタおよびそれを備える溶解液容器
GB2388025A (en) * 2002-04-06 2003-11-05 Pharmaceutical Bulk Substances Kit for preparing a formulation of paclitaxel
JP4427965B2 (ja) * 2002-07-02 2010-03-10 ニプロ株式会社 連通手段付き薬液容器
US7488309B2 (en) * 2002-07-03 2009-02-10 Bioanalytical Systems, Inc. Device and method for drug delivery to animals
AU2003291458A1 (en) * 2002-11-08 2004-06-03 Bristol-Myers Squibb Company Pharmaceutical compositions and methods of using taxane derivatives
JP2006517969A (ja) * 2003-02-14 2006-08-03 コンビナトアールエックス インコーポレーティッド 免疫炎症性障害の治療のための組み合わせ療法
JP2007528402A (ja) * 2004-03-09 2007-10-11 エラン ファーマシューティカルズ，インコーポレイテッド 置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬

Also Published As

Publication number Publication date
KR20080058389A (ko) 2008-06-25
CY1116161T1 (el) 2017-02-08
RU2446828C2 (ru) 2012-04-10
HUE024968T2 (en) 2016-02-29
EP1928501A2 (fr) 2008-06-11
JP2009509608A (ja) 2009-03-12
HK1117420A1 (en) 2009-01-16
IL190323A0 (en) 2009-09-22
BRPI0617588A2 (pt) 2011-08-02
UA93060C2 (ru) 2011-01-10
US8182449B2 (en) 2012-05-22
DK1928501T3 (en) 2015-04-20
PL1928501T3 (pl) 2015-07-31
EP1928501B1 (fr) 2015-01-07
CA2624047A1 (fr) 2007-04-05
IL190323A (en) 2014-07-31
CA2624047C (fr) 2016-01-05
AU2006296350A1 (en) 2007-04-05
SI1928501T1 (sl) 2015-06-30
WO2007036792A3 (fr) 2007-08-30
RU2008116812A (ru) 2009-11-10
US20090264830A1 (en) 2009-10-22
ITMI20051826A1 (it) 2007-03-30
MD20080116A (ro) 2008-10-31
RS53934B1 (sr) 2015-08-31
HRP20150393T1 (hr) 2015-05-22
ZA200802745B (en) 2009-05-27
CN101316614A (zh) 2008-12-03
AU2006296350B2 (en) 2012-08-30
PT1928501E (pt) 2015-04-23
TNSN08144A1 (en) 2009-07-14
ES2534416T3 (es) 2015-04-22
WO2007036792A2 (fr) 2007-04-05

Similar Documents

Publication Publication Date Title
NO20081559L (no) Kit for parenteral administrering av medikamenter
ECSP066734A (es) Derivados de ácido 7-fenilamino-4-quinolona-3-carboxílico, métodos para su producción y su uso como medicamentos
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
NO20071505L (no) Fremgangsmate for sammensetting av legemiddelavgivelsesanordninger.
NO20061245L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en bisfosfon
EP2004172A4 (fr) Méthodes d'administration de médicaments, structures et compositions utilisées dans le système nasolacrymal
DE602005010788D1 (de) Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
EP2231203A4 (fr) Seringue et système et méthode d'administration d'ozone
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
AR086356A1 (es) Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
UY28923A1 (es) Compuestos terapéuticos: piridina como estructura base
DK2244703T3 (da) Lægemiddel og fremstillingen og anvendelse deraf i behandlingen af smertefulde neuropatier
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
UY29245A1 (es) Combinaciones medicas
UY29244A1 (es) Combinaciones medicas
CO6311083A2 (es) 4-((1r,3s)-6-cloro-3-fenilindan-1-il)-1,2,2-trimetilpiperazina para el tratamiento de la disfunción cognitiva
WO2006131923A3 (fr) Nouveaux sels de medicaments psychotropes conjugues et leurs procedes de preparation
MXPA06007510A (es) Composiciones de farmaco y formas de dosis novedosas de topiramato.
BRPI0414518A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano
ECSP109871A (es) Soluciones farmacéuticas orales que contienen telbivudina
IS8413A (is) Læknisfræðileg meðferðaráform til inngjafar á lyfjasamsetningum

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application